The end of the federal COVID-19 Public Health Emergency marks a major shift in the U.S. response to the coronavirus. This change affects everything from health insurance coverage to data reporting. With the emergency declaration over, free access to COVID-19 tests, treatments, and vaccines may be limited, with costs shifting to individuals and private insurers. The article explains the practical implications of this transition for the American public and the healthcare system.
